https://doi.org/10.1186/s13046-021-02207-y
L
Liwei Lang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
1.4K
Citations
23
h-index
34
i10-index
Liwei Lang is an academic researcher from Augusta University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer, Hypoxia, and Metabolism & Cancer Cells and Metastasis. The author has an h-index of 23, co-authored 97 publications.
ORCID: 0000-0002-2374-645XPapers by this author
worksBlockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer
2021 · Journal of Experimental & Clinical Cancer Research · 54 citations
ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development
2022 · Journal of Experimental & Clinical Cancer Research · 47 citations
https://doi.org/10.1186/s13046-022-02274-9
Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer
2019 · Journal of Experimental & Clinical Cancer Research · 46 citations
https://doi.org/10.1186/s13046-019-1124-0
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics
2017 · Journal of Experimental & Clinical Cancer Research · 31 citations
https://doi.org/10.1186/s13046-017-0583-4
The Complexity of DEK Signaling in Cancer Progression
2017 · Current Cancer Drug Targets · 15 citations
https://doi.org/10.2174/1568009617666170522094730
SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis
2025 · Biomarker Research · 15 citations
https://doi.org/10.1186/s40364-025-00726-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat